Tag Archives: NPSP

Healthcare Sector Quick Snapshot; NPS Pharmaceuticals (NPSP) Soars to Highest Level after FDA Staff Report while Lexicon Pharmaceuticals (LXRX) Surges on New Data for Telotristat – NPSP, LXRX, MRK, AEGR, XNPT

Posted on October 15, 2012 by Thomas Vedder

Healthcare sector reacted negatively on last trading session of the week and sector slightly fell, -0.01%. If we consider top movers of the sector so NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) were major percentage gainers while major …

Posted in Healthcare, Latest Headlines | Tagged Aegerion, AEGR, Lexicon, LXRX, Merck, MRK, NASDAQ:AEGR, NASDAQ:LXRX, NASDAQ:NPSP, NASDAQ:XNPT, NPS, NPSP, NYSE:MRK, XenoPort, XNPT | Comments Off

NPS Pharmaceuticals (NASDAQ:NPSP) Wins EU Experts Panel Approval; Stocks Climbs – NPSP, AMGN, TEVA, ABT

Posted on June 25, 2012 by Thomas Vedder

NPS Pharmaceuticals, Inc’s (NASDAQ:NPSP) stock surged on Friday after the drug maker reported that a board of European Union specialists recommended approval for its bowel medicine teduglutide.

The European Medicines Agency is not necessary to track the advice from its …

Posted in Healthcare, Latest Headlines | Tagged Abbott Laboratories, ABT, Amgen, AMGN, NASDAQ:AMGN, NASDAQ:NPSP, NPS Pharmaceuticals, NPSP, NYSE:ABT, NYSE:TEVA, TEVA, Teva Pharmaceutical | Comments Off

Centene, Molina back in Ohio Medicaid business – CNC, MOH, ARNA, PFE, ZLCS, ILMN, NPSP, COO

Posted on June 8, 2012 by Thomas Vedder

St. Louis-based Centene Corp (NYSE:CNC) and Molina Healthcare, Inc. (NYSE:MOH) have each been rewarded Medicaid managed care agreements in Ohio in a rearranging of the before reported five winning bidders.

In April, Centene and Long Beach, Calif.-based Molina were amid …

Posted in Healthcare, Latest Headlines | Tagged Arena Pharmaceuticals, ARNA, Centene, CNC, COO, Cooper, Illumina, ILMN, MOH, Molina Healthcare, NASDAQ:ARNA, NASDAQ:ILMN, NASDAQ:NPSP, NASDAQ:ZLCS, NPS Pharmaceuticals, NPSP, NYSE:CNC, NYSE:COO, NYSE:MOH, NYSE:PFE, PFE, Pfizer, Zalicus, ZLCS | Comments Off

Big time losers and the reasons why (NPSP, CYOU, FSLR)

Posted on October 31, 2011 by Martin Timble

In this report: NSP Pharmaceuticals (NASDAQ:NPSP), Changyou.com (NASDAQ:CYOU) and First Solar (NASDAQ:FSLR).

NSP Pharmaceuticals (NASDAQ:NPSP) has plummeted by more than 36 percent today after it was announce that three people who where in a clinical trial for the drug Gattex …

Posted in Latest Headlines, Reports | Tagged adjusted, Analysts, Buy, cancer, CEO, Changyou.com, clinical trial, company, CYOU, died, downgrades, earnings, estimate, expected, First Solar, FSLR, Gattex, Joe Osha, Merrill Lynch, NASDAQ:CYOU, NASDAQ:FSLR, NASDAQ:NPSP, net income, NPSP, NSP Pharmaceuticals, quarterly, rating, reported, results, revenue, Rob Gillette, share, Solar, Wall Street | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: NPSP

Healthcare Sector Quick Snapshot; NPS Pharmaceuticals (NPSP) Soars to Highest Level after FDA Staff Report while Lexicon Pharmaceuticals (LXRX) Surges on New Data for Telotristat – NPSP, LXRX, MRK, AEGR, XNPT

NPS Pharmaceuticals (NASDAQ:NPSP) Wins EU Experts Panel Approval; Stocks Climbs – NPSP, AMGN, TEVA, ABT

Centene, Molina back in Ohio Medicaid business – CNC, MOH, ARNA, PFE, ZLCS, ILMN, NPSP, COO

Follow us

Most Popular Posts

blogs